Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
Healthcare4- Page
177Articles
NHS staff outperformed government expectations last year, delivering a sharp improvement in productivity and offering a timely win for Chancellor Rachel Reeves ahead of the crucial autumn Budget. For the
Recent public announcements of cancer diagnoses by high-profile figures have inadvertently contributed to significant delays in the National Health Service’s cancer referral process, a senior coroner has observed. Samantha Goward,
Bristol Myers Squibb BMS has issued a pointed demand for the NHS to fund a greater share of pharmaceutical innovation calling for the UK to pay what it describes as
The National Health Service is making a significant stride towards modernising diagnostics with the introduction of a cloud-based screening platform designed to accelerate the identification of chronic diseases. With an
Spire Healthcare, one of the United Kingdom’s leading private healthcare providers, is actively weighing up a potential sale. The company, currently listed on the FTSE 250, faces mounting discontent from
Novo Nordisk, headquartered in Copenhagen, has seen its shares surge by more than 6 per cent after unveiling promising results from a late-stage clinical trial of its new anti-obesity tablet.
The battle between the NHS and pharmaceutical giants is reaching boiling point as accusations fly over the UK’s approach to funding modern medicines. A fresh row has ignited during President
Shareholders of Assura, a leading landlord to the NHS, have voted decisively to merge with Primary Health Properties (PHP) rather than accept a £1.7 billion all-cash takeover from American private
Profits at Bupa the UK’s most recognised private healthcare provider have surged by nearly a fifth as growing numbers of patients look beyond the NHS due to record waiting times
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
Shares in European drug companies slumped to a four-month low on Wednesday, after US President Donald Trump reiterated his intention to impose tariffs on pharmaceutical imports in a bid to
Alzheimers patients can extend cognitive health for years with breakthrough drugs ||| Groundbreaking trial results have revealed that radical new treatments can effectively stall the progression of Alzheimer’s disease for
The impending strike by resident doctors in the NHS is set to take place from 7am on Friday 25 July to 7am on Wednesday 30 July 2025. This strike follows
Assura the NHS landlord at the centre of a lengthy bidding war has reported strong annual results that strengthen shareholder resolve to resist a buyout by private equity. The FTSE
Superbugs could cause a dramatic surge in global deaths and inflict economic losses nearing $2 trillion each year by 2050, new research reveals. Projections from a UK government-backed study, led
